Compared with claudin-1 mRNA expression in the small intestine as well as the colonic mucosa of the control group, it was significantly decreased in diarrhea-predominant IBS (P<0.05), while it was significantly increased in constipation-predominant IBS (P<0.05) (Fig. 3). This evidence concerns the gene CLDN1 and irritable bowel syndrome.